Full Text View
Tabular View
No Study Results Posted
Related Studies
Chinese Assessment for Vinpocetine In Neurology (CAVIN)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by Shanghai Rxmidas Pharmaceuticals Co. Ltd..
Recruitment status was  Recruiting
Study NCT01400035   Information provided by Shanghai Rxmidas Pharmaceuticals Co. Ltd.

First Received on July 19, 2011.   Last Updated on July 21, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cerebral Infarction
Additional conditions recognized in this trial
Infarction
Stroke
More general conditions related to this trial
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Ischemia
Necrosis
Nervous System Diseases
Pathologic Processes
Vascular Diseases
Additional drug interventions recognized in this trial
Cytidine Diphosphate Choline
Vinpocetine
More general drug interventions related to this trial
Cardiovascular Agents
Central Nervous System Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Nootropic Agents
Pharmacologic Actions
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Shanghai Rxmidas Pharmaceuticals Co. Ltd.
Gedeon Richter Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services